These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6856597)
1. [Anti-androgenic activity of various substituted carboxyanilides]. Varga SV; Reznikov AG; Bal'on IaG; Lozinskiĭ MO; Smirnov VA Probl Endokrinol (Mosk); 1983; 29(2):67-71. PubMed ID: 6856597 [TBL] [Abstract][Full Text] [Related]
2. On the mechanism of the anti-androgenic action of flutamide (alpha-alpha-alpha-trifluoro-2-methyl-4'-nitro-m-propionotoluidide) in the rat. Peets EA; Henson MF; Neri R Endocrinology; 1974 Feb; 94(2):532-40. PubMed ID: 4810387 [No Abstract] [Full Text] [Related]
3. Effect of alpha, alpha, alpha-trifluoro-2-methyl-4'-nitro-m-lactotoluidide (Sch 16423) on serum testosterone and LH in rats. Clark CR; Merry BJ; Nowell NW J Reprod Fertil; 1981 Jan; 61(1):189-91. PubMed ID: 7452616 [TBL] [Abstract][Full Text] [Related]
4. Flutamide. Mechanism of action of a new nonsteroidal antiandrogen. Sufrin G; Coffey DS Invest Urol; 1976 May; 13(6):429-34. PubMed ID: 1270239 [TBL] [Abstract][Full Text] [Related]
6. [Nucleic acid and protein biosynthesis in the accessory sex organs of rats during blockade of testosterone effect by androgen antagonist 4-nitro-3-trifluoromethylisobutyranilide]. Varga SV; Sinitsyn PV Probl Endokrinol (Mosk); 1978; 24(1):107-11. PubMed ID: 634940 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology and pharmacokinetics of flutamide. Neri R Urology; 1989 Oct; 34(4 Suppl):19-21; discussion 46-56. PubMed ID: 2477934 [TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides. Tucker H; Crook JW; Chesterson GJ J Med Chem; 1988 May; 31(5):954-9. PubMed ID: 3361581 [TBL] [Abstract][Full Text] [Related]
11. [The pharmacologic profile of flutamide]. Racca S; Di Carlo F G Ital Chemioter; 1985; 32(1):7-11. PubMed ID: 2937678 [No Abstract] [Full Text] [Related]
12. [Participation of the hypothalamus in the pituitary and testicular responses to administration of the antiandrogen 4-nitro-3-trifluoro-methylisobutyranilide]. Reznikov AG; Volkova NN Biull Eksp Biol Med; 1979 Nov; 88(11):601-3. PubMed ID: 120207 [TBL] [Abstract][Full Text] [Related]
13. Anti-androgen TSAA-291. VII. On the mechanism of anti-androgenic action of 16 beta-ethyl-17 beta-hydroxy-4-oestren-3-one (TSAA-291). Nakayama R; Masuoka M; Hiraga K; Miki T Acta Endocrinol Suppl (Copenh); 1979; 229():100-7. PubMed ID: 294104 [TBL] [Abstract][Full Text] [Related]
14. [Nonsteroidal antiandrogen inhibition of testosterone metabolism in the prostate]. Reznikov AG; Korpacheva TI Probl Endokrinol (Mosk); 1988; 34(2):64-7. PubMed ID: 3393507 [TBL] [Abstract][Full Text] [Related]
15. Antiandrogenic activity of a series of des-A-steroid derivatives. Morales-Alanis H; Brienne MJ; Jacques J; Bouton MM; Nédélec L; Torelli V; Tournemine C J Med Chem; 1985 Dec; 28(12):1796-803. PubMed ID: 4068004 [TBL] [Abstract][Full Text] [Related]
16. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney. Kontula KK; Seppänen PJ; van Duyne P; Bardin CW; Jänne OA Endocrinology; 1985 Jan; 116(1):226-33. PubMed ID: 3964747 [TBL] [Abstract][Full Text] [Related]
17. Anti-androgenicity of flutamide and its metabolite Sch 16423. Neri R; Peets E; Watnick A Biochem Soc Trans; 1979 Jun; 7(3):565-9. PubMed ID: 446862 [No Abstract] [Full Text] [Related]
18. [Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications]. Akakura K; Furuya Y; Ito H Nihon Rinsho; 1998 Aug; 56(8):2124-8. PubMed ID: 9750520 [TBL] [Abstract][Full Text] [Related]
19. [Androgen formation in the testes of hypophysectomized rats exposed to the antiandrogen niftolid (flutamide)]. Volkova NN Probl Endokrinol (Mosk); 1982; 28(3):76-8. PubMed ID: 7100132 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders. Battmann T; Branche C; Bouchoux F; Cerede E; Philibert D; Goubet F; Teutsch G; Gaillard-Kelly M J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):103-11. PubMed ID: 9569015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]